دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران
| English 
نسخه چاپی
مجید داوري
اطلاعات تماس
تلفن: 02164121137
فکس: 02166482606
مرتبه علمی
دانشیار
دانشکده
داروسازي
اقتصاد و مديريت دارو
درباره
لینکها
آخرین به روزرسانی: 1398/12/20
1.
صحبت: Native, خواندن: Native, نوشتن: Native
Farsi
صحبت: Native, خواندن: Native, نوشتن: Native
2.
صحبت: Good, خواندن: Good, نوشتن: Good
English
صحبت: Good, خواندن: Good, نوشتن: Good
3.
صحبت: Poor, خواندن: Good, نوشتن: Poor
Arabic
صحبت: Poor, خواندن: Good, نوشتن: Poor
Ph.D
1.
1393-Present Tehran University of Medical Sci,Ph.D.
Economic Analysis of Public Health
1393-Present Tehran University of Medical Sci,Ph.D.
2.
1393-Present Tehran University of Medical Sci,Ph.D.
Economics of Health Care
1393-Present Tehran University of Medical Sci,Ph.D.
3.
1387-Present Tehran University of Medical Sci,Ph.D.
Pharmacoeconomics / Economic Evaluation
1387-Present Tehran University of Medical Sci,Ph.D.
4.
1387-1392 Shahid Beheshti Medical Universi,Ph.D.
Modelling in Pharmacoeconomics
1387-1392 Shahid Beheshti Medical Universi,Ph.D.
5.
1387-1390 Isfahan University of Medical Sc,Ph.D.
Economics of Health Policy
1387-1390 Isfahan University of Medical Sc,Ph.D.
Pharm D
1.
1393-Present Tehran University of Medical S,Pharm D.
Pharmacy Management
1393-Present Tehran University of Medical S,Pharm D.
2.
1386-1388 Isfahan University of Medical Sc,Pharm D.
Pharmacy Management
1386-1388 Isfahan University of Medical Sc,Pharm D.
M.Sc
1.
1389-1390 Azad University,M.Sc.
Pharmaceutical Policy
1389-1390 Azad University,M.Sc.
Supervisor
1.
Cost-effectiveness analysis of Topotecan in compared with Paclitaxel and Doxorubicin in treatment metastatic ovarian cancer
Behrooz Rajabkhah,
M.Sc, Health Technology Assessment, 2016 2.
Cost-Effectiveness analysis of pregabalin and gabapentin in management of neuropathic pain in spinal cord injury in Iran
Bahman Amani,
M.Sc, Health Technology Assessment, 2016 3.
Cost-Utility Analysis of Prophylaxis versus On-Demand treatment in patients with severe Hemophilia A in Iran
Zahra Gharib-Naseri,
Ph.D, Pharmacoeconomics & Pharmaceutical Management, 2016 4.
Cost -Effectiveness Analysis Of Cinacalcet For SHPTin ESRD patient on Haemodialysis in Iranian Pharmaceutical market
Niloufar Sharahi,
M.Sc, Pharmaceutical Monitoring , 2015 5.
The direct medical costs of acute lymphocytic leukemia (ALL) in children in Isfahan, Iran
Elham Khayyam,
M.Sc, Financial Management, 2013 6.
The impact of family physician programme on financial indicators in Charmahal & Bakhtyari province, Iran
Maryam Kheyri,
Ph.D, Social Medicine, 2013 7.
The direct medical costs of breast cancer in Iran
Farkhondeh Yazdan-Panah,
B.Sc, Pharmacy, 2012 8.
The direct medical costs of colorectal cancer in Iran
Said Massah,
Pharm D, Pharmacy, 2012 9.
The direct medical costs of Diabetes in Iran
Zahra Boroumand,
Pharm D, Pharmacy, 2012 10.
Cost–effectiveness analysis of cetuximab in treatment of colorectal cancer in Iranian pharmaceutical market
Mohammad Tabatabaei,
Pharm D, Pharmacy, 2011 11.
Evaluation of Equity in Pharmaceutical Services in Selected city of Kurdestan
Mohammad Saleh Amini,
Pharm D, Pharmacy, 2010 12.
Iranian Pharmaceutical Industry and the Challenges of Joining the WTO
Habib Rajaei,
Pharm D, Pharmacy, 2010 13.
Cost-Effectiveness Analysis of Trastuzumab in early stages of the breast cancer
Nastaran Heydarzadeh,
Pharm D, Pharmacy, 2010 14.
Cost-Effectiveness Analysis of Clopidogrel versus Ticlopidin in managing myocardial infarction after stent
Mostafa Hosseini,
Pharm D, Pharmacy, 2010 15.
Cost-Effectiveness Analysis of Colorectal Cancer Screening Methods in the Iran
Zahra Allame,
Pharm D, Pharmacy, 2009 16.
. Evaluation of Equity in Pharmaceutical Services in Selected city of Isfahan
Zahra Bakhshizade,
Pharm D, Pharmacy, 2009 17.
Effectiveness Analysis of Clopidogrel versus Ticlopidin in managing myocardial infarction after stent
Fatemeh Kodaei,
Pharm D, Pharmacy, 2009 مقالات
English
1.
Authors: Gharibnaseri, Z. Davari, M. Cheraghali, A. Eshghi, P. Ravanbod, R. Espandar, R. Hantooshzadeh, R.
Transfusion and Apheresis Science, Vol.54, No.1, Year. 2016,
Health care resource utilization and cost of care for haemophilia A and B patients in Iran
Authors: Gharibnaseri, Z. Davari, M. Cheraghali, A. Eshghi, P. Ravanbod, R. Espandar, R. Hantooshzadeh, R.
Transfusion and Apheresis Science, Vol.54, No.1, Year. 2016,
2.
Authors: Majid Davari · Zahra Boroumand · Masoud Amini · Mohsen Hosseini
International journal of preventive medicine, Vol.7, No.1, Year. 2016,
The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
Authors: Majid Davari · Zahra Boroumand · Masoud Amini · Mohsen Hosseini
International journal of preventive medicine, Vol.7, No.1, Year. 2016,
3.
Authors: Majid Davari, Elahe Khorasani, Zahra Bakhshizade, Marzie Jafarian Jazi, Mohsen Ghaffari Darab, Mohammad Reza Maracy
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol.14, No.4, Year. 2015,
. Evaluation of equity in access to pharmaceutical services in selected cites of Isfahan province (Iran
Authors: Majid Davari, Elahe Khorasani, Zahra Bakhshizade, Marzie Jafarian Jazi, Mohsen Ghaffari Darab, Mohammad Reza Maracy
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol.14, No.4, Year. 2015,
4.
Authors: Davari, M. Ashrafi, F. Maracy, M. Aslani, A. Tabatabaei, M.
Int J Prev Med, Vol.6, No.63, Year. 2015,
Cost-effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market
Authors: Davari, M. Ashrafi, F. Maracy, M. Aslani, A. Tabatabaei, M.
Int J Prev Med, Vol.6, No.63, Year. 2015,
5.
Authors: Davari, M. Khorasani, E. Bakhshizade, Z. Jafarian Jazi, M. Ghaffari Darab, M. Maracy, M. R.
Iran J Pharm Res, Vol.14, No.4, Year. 2015,
Measuring Equity in Access to Pharmaceutical Services Using Concentration Curve; Model Development
Authors: Davari, M. Khorasani, E. Bakhshizade, Z. Jafarian Jazi, M. Ghaffari Darab, M. Maracy, M. R.
Iran J Pharm Res, Vol.14, No.4, Year. 2015,
6.
Authors: Khadivi, R. Kheyri M. Davari, M. Nourbakhsh SK
International Journal of Current Life Sciences , Vol.4, No.8, Year. 2014,
; Does Family Physician Programme in Iran Improve Financial Contribution of the patients
Authors: Khadivi, R. Kheyri M. Davari, M. Nourbakhsh SK
International Journal of Current Life Sciences , Vol.4, No.8, Year. 2014,
7.
Authors: Davari, M. Maracy, M.R. Mokhtari, M. Ghorashi Z
Health Information Management, Vol.10, No.2, Year. 2014,
Relationship between socioeconomic factors and request for caesarean delivery in nulliparous women in Niknafs educational health centre of Rafsanjan
Authors: Davari, M. Maracy, M.R. Mokhtari, M. Ghorashi Z
Health Information Management, Vol.10, No.2, Year. 2014,
8.
Authors: Davari, M. Khorasani, E. Bakhshizade, Z. Jafarian Jazi, M. Ghaffari Darab, M. Maracy, M. R.
Vol.17, No.7, Year. 2014,
A Single Model For Determining Socioeconomic Status in Health Studies; A Crucial Step To Make The Results More Comparable
Authors: Davari, M. Khorasani, E. Bakhshizade, Z. Jafarian Jazi, M. Ghaffari Darab, M. Maracy, M. R.
Vol.17, No.7, Year. 2014,
9.
Authors: Davari, M. Yazdanpanah F, Aslani A, Hosseini M, Nazari AR, Mokarian F
International Journal of Preventive Medicine , Vol.4, No.7, Year. 2013,
The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient’s Level Data from a Cancer Specific Hospital in Isfahan
Authors: Davari, M. Yazdanpanah F, Aslani A, Hosseini M, Nazari AR, Mokarian F
International Journal of Preventive Medicine , Vol.4, No.7, Year. 2013,
10.
Authors: .Davari, M. Emami, M.H. Maracy, M.R. et.al
. International Journal of Preventive Medicine, Vol.3, No.12, Year. 2012,
The direct medical costs of colorectal cancer in Iran; analyzing the patient's level data from a cancer specific hospital in Isfahan
Authors: .Davari, M. Emami, M.H. Maracy, M.R. et.al
. International Journal of Preventive Medicine, Vol.3, No.12, Year. 2012,
11.
Authors: .Davari, M. Emami, M.H. Maracy, M.R. et.al
. International Journal of Preventive Medicine, Vol.3, No.12, Year. 2012,
The direct medical costs of colorectal cancer in Iran; analyzing the patient's level data from a cancer specific hospital in Isfahan
Authors: .Davari, M. Emami, M.H. Maracy, M.R. et.al
. International Journal of Preventive Medicine, Vol.3, No.12, Year. 2012,
12.
Authors: Davari, M. Haycox, A. Walley, T
Iranian Journal of Public Health , Vol.41, No.7, Year. 2012,
?Health care financing in Iran; is privatisation a good solution
Authors: Davari, M. Haycox, A. Walley, T
Iranian Journal of Public Health , Vol.41, No.7, Year. 2012,
13.
Authors: .Davari, M. Haycox, A. Walley, T
Iranian Journal of Public Health , Vol.41, No.9, Year. 2012,
. The Iranian Health Insurance system; past experiences, present challenges and future strategies
Authors: .Davari, M. Haycox, A. Walley, T
Iranian Journal of Public Health , Vol.41, No.9, Year. 2012,
14.
Authors: Davari, M
Iranian J of Pharmaceutical Research, Vol.11, No.1, Year. 2012,
Pharmacoeconomics; an appropriate tool for policy makers or just a new field of research in Iran
Authors: Davari, M
Iranian J of Pharmaceutical Research, Vol.11, No.1, Year. 2012,
15.
Authors: Kalantari, H. Davari, M. Akbari, M. et al.
International Journal of Preventive Medicine, Vol.3, No.3, Year. 2011,
The estimation of direct medical costs of treating patients with chronic hepatitis B and C in Iran
Authors: Kalantari, H. Davari, M. Akbari, M. et al.
International Journal of Preventive Medicine, Vol.3, No.3, Year. 2011,
16.
Authors: Kazemi S, Daghaghzade H, Kazemi Y, Habibzade M, Moinzade F, Davari M, Tavakoli H, Imami, M.H,
Journal of Isfahan Medical School, Vol.29, Year. 2011,
Comparative study on costs and effects of noninvasive Helicobacter pylori diagnostic tests
Authors: Kazemi S, Daghaghzade H, Kazemi Y, Habibzade M, Moinzade F, Davari M, Tavakoli H, Imami, M.H,
Journal of Isfahan Medical School, Vol.29, Year. 2011,
17.
Authors: Davari M. Walley T. Haycox A.
Journal of Pharmaceutical Health Services Research, Vol.2, Year. 2011,
Pharmaceutical policy and market in Iran, past experiences and future challenges
Authors: Davari M. Walley T. Haycox A.
Journal of Pharmaceutical Health Services Research, Vol.2, Year. 2011,
18.
Authors: Allame, Z. Davari, M. Imami, M.
Archive of Iranian Medicine, Vol.14, No.2, Year. 2011,
Cost-Effectiveness Analysis of Colorectal Cancer Screening Methods in the Iran
Authors: Allame, Z. Davari, M. Imami, M.
Archive of Iranian Medicine, Vol.14, No.2, Year. 2011,
19.
Authors: Allameh, Zahra Davari, Majid Emami, Mohammad Hassan
Iranian Journal of Cancer Prevention, Vol.4, No.2, Year. 2011,
Sensitivity and specificity of colorectal cancer mass screening methods: a systematic review of the literature
Authors: Allameh, Zahra Davari, Majid Emami, Mohammad Hassan
Iranian Journal of Cancer Prevention, Vol.4, No.2, Year. 2011,
20.
Authors: Davari, M. Haycox, A., Walley, T.
Iranian Journal of Public Health, Vol. Suppl, Year. 2005,
HEALTH CARE CHALLENGES IN IRAN
Authors: Davari, M. Haycox, A., Walley, T.
Iranian Journal of Public Health, Vol. Suppl, Year. 2005,
21.
Authors: Davari, Majid Haycox, Alan Walley, Tom
CELLULAR & MOLECULAR BIOLOGY LETTERS , Vol.9, No.Supplement, Year. 2004,
N.I.C.E. LESSONS FOR IRAN
Authors: Davari, Majid Haycox, Alan Walley, Tom
CELLULAR & MOLECULAR BIOLOGY LETTERS , Vol.9, No.Supplement, Year. 2004,
Farsi
1.
Authors: Davari M. Moafi A. Yarmohammadian M.H. Khayyam E.
Health Information Management, Vol.14, No.4, Year. 2015,
The direct medical costs of acute lymphocytic leukemia (ALL) in children in Isfahan, Iran
Authors: Davari M. Moafi A. Yarmohammadian M.H. Khayyam E.
Health Information Management, Vol.14, No.4, Year. 2015,
2.
Authors: .Davari, M. Walley, T., Haycox, A
Health Information Management, Vol.10, No.6, Year. 2014,
A HTA system for Iran, luxury or a real need
Authors: .Davari, M. Walley, T., Haycox, A
Health Information Management, Vol.10, No.6, Year. 2014,
3.
Authors: Davari, Majid Walley, Tom Haycox, Alan
Health Information Journal , Vol.10, No.6, Year. 2013,
Health Technology Assessment Programme for Iran; A Luxury or Real Need?
Authors: Davari, Majid Walley, Tom Haycox, Alan
Health Information Journal , Vol.10, No.6, Year. 2013,
4.
Authors: Davari, M
Health Information Management, Vol.8, No.7, Year. 2012,
The economic challenges of health system in Iran
Authors: Davari, M
Health Information Management, Vol.8, No.7, Year. 2012,
5.
Authors: Davari, M. Kohan, S. Enjezab, B. Javadnouri, M.
Health Information Management, Vol.8, No.7, Year. 2012,
Promoting the efficient use of human resources in reproductive health services in Iran; a Cost-service analysis
Authors: Davari, M. Kohan, S. Enjezab, B. Javadnouri, M.
Health Information Management, Vol.8, No.7, Year. 2012,
1. Economic Evaluation
Economic evaluation is the process of systematic identification, measurement and valuation of the inputs and outcomes of two alternative activities, and the subsequent comparative analysis of these. The purpose of economic evaluation is to identify the best course of action, based on the evidence available. Economic evaluations can be completedby various forms such ascost effectiveness analysis and cost utility analysis.
2. Efficiency
Efficiency is a measurable concept that can be calculated by determining the ratio of useful output to total input. An efficiency study addresses the questions of Allocative efficiency or Technical efficiency. Allocative efficiency assesses competing programs and judges the extent to which they meet objectives. Technical efficiency assesses the best way of achieving a given objective.
3. Equity
Top
Equity is defined as fairness or justice in the way people are treated. Within the context of health and health care, equity is divided in equity in access and equity in finance. Equity in access addresses systematic inequality of access to health care / health in different groups of people. Equity in health care financing is assessed by the degree of inequality in paying for health care between households of unequal Ability To Pay (ATP). It is usually represented by the extent to which health care is financed according to ATP.